Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.73
25.04.24
-
25.04.25
2.28%
07:24

Risky Investment
Global_Player 
25.04.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-1.53%
07:24

Could be worthwhile Investment >10% per year
Global_Player 
25.04.24 50%
buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.81
15.04.24
€3.00
31.10.25
-
15.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 60%
sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-6.54%
01:00

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
nvestor 
13.04.24 50%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-31.27%
01:00

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
nvestor 
13.04.24 50%
sell
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-9.27%
01:00

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
nvestor 
13.04.24 50%
buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.72
11.04.24
-
11.04.25
-12.21%
14.04.24

Could be worthwhile Investment >10% per year
Wolf_of_WS 
11.04.24 50%
sell
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.50
11.04.24
-
11.04.25
3.27%
14.04.24

Risky Investment
Global_Player 
11.04.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€66.50
07.04.24
-
07.04.25
0.75%
14.04.24

Could be very worthwhile Investment >20% year
Vassago1 
07.04.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.11
02.04.24
-
02.04.25
-38.74%
16.04.24

Could be very worthwhile Investment >20% year
thomasw 
02.04.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.14
02.04.24
-
02.04.25
-28.14%
13.04.24

Could be worthwhile Investment >10% per year
melinda 
02.04.24 10%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.60
02.04.24
-
02.04.25
-48.88%
13.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
02.04.24 0%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.64
28.03.24
-
28.03.25
-40.27%
31.03.24

Risky Investment
Vassago1 
28.03.24 50%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.55
28.03.24
-
28.03.25
-38.27%
30.03.24

Could be worthwhile Investment >10% per year
daimler1 
28.03.24 50%
sell
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.88
26.03.24
-
26.03.25
-18.09%
31.03.24

Risky Investment
Vassago1 
26.03.24 50%
sell
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€1.06
26.03.24
-
26.03.25
-1.69%
31.03.24

Risky Investment
Vassago1 
26.03.24 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€2.69
22.03.24
-
22.03.25
-16.73%
30.03.24

Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
me8 
22.03.24 0%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.57
21.03.24
-
21.03.25
-38.64%
31.03.24

Could be very worthwhile Investment >20% year
bundfuture 
21.03.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.22
21.03.24
-
21.03.25
2.97%
29.03.24

Probably not worthwhile Investment
thomasw 
21.03.24 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
18.03.24
-
18.03.25
2.26%
30.03.24

Could be worthwhile Investment >10% per year
Wolf_of_WS 
18.03.24 50%
sell
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
17.03.24
€0.30
30.11.25
76.96%
28.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
sell
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
17.03.24
€3.00
31.01.26
60.34%
25.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Inventiva SA

Start price
Target price
Perf. (%)
€3.71
17.03.24
€5.00
31.01.26
-2.70%
19.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€10.20
17.03.24
€16.00
30.06.26
-8.82%
19.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
16.03.24
€2.00
16.03.25
2.26%
30.03.24

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
mixitrader 
16.03.24 50%